72.10

3.16% 2.0784

Praxis Precision Medicines Inc (PRAX)

Overview News Price History Option Chain Financials Discussions Forecast

Praxis Precision Medicines Inc stock is traded at $72.10, with a volume of 59,216. It is up +3.16% in the last 24 hours and up +11.23% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.

Previous Close:

$70.02

Open:

$70.02

24h Volume:

59,216

Relative Volume:

0.24

Market Cap:

$1.25B

Revenue:

Net Income/Loss:

$-123.28M

P/E Ratio:

-23.79

EPS:

-3.03

Net Cash Flow:

$-111.14M

1W Performance:

+1.69%

1M Performance:

+11.23%

6M Performance:

+32.43%

1Y Performance:

+6,349%

1-Day Range:

$69.20

$72.77

1-Week Range:

$67.36

$72.77

52-Week Range:

$0.867

$75.73

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name

Praxis Precision Medicines Inc

Sector

Healthcare (1181)

Industry

Biotechnology (680)

Phone

617-300-8460

Address

99 HIGH STREET, 30TH FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

PRAX's Discussions on Twitter

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-19-23	Initiated	Truist	Buy
Jun-06-22	Downgrade	Wedbush	Outperform → Neutral
Dec-16-21	Initiated	H.C. Wainwright	Buy
Aug-26-21	Initiated	BofA Securities	Buy
Apr-26-21	Initiated	William Blair	Outperform
Nov-11-20	Initiated	Wedbush	Outperform
Nov-10-20	Initiated	Cowen	Outperform
Nov-10-20	Initiated	Evercore ISI	Outperform
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

Nov 03, 2024

Assenagon Asset Management S.A. Decreases Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Nov 03, 2024

Nov 02, 2024

Praxis Precision Medicines (PRAX) to Release Quarterly Earnings on Wednesday - MarketBeat

Nov 02, 2024

Nov 01, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 - GlobeNewswire

Nov 01, 2024

Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024 - StockTitan

Nov 01, 2024

Oct 26, 2024

(PRAX) Trading Advice - Stock Traders Daily

Oct 26, 2024

Oct 24, 2024

Moody Aldrich Partners LLC Purchases 7,224 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 24, 2024

Oct 21, 2024

We're Not Very Worried About Praxis Precision Medicines' (NASDAQ:PRAX) Cash Burn Rate - Yahoo Finance

Oct 21, 2024

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat

Oct 21, 2024

Oct 16, 2024

Praxis Precision Medicines revises executive severance terms By Investing.com - Investing.com Australia

Oct 15, 2024

Praxis Precision To Reveal Key Trial Data On Essential Tremors - RTTNews

Oct 15, 2024

Dimensional Fund Advisors LP Sells 8,152 Shares of Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 15, 2024

Oct 14, 2024

Praxis Precision shares get boost on DEE space acquisition interest - Investing.com India

Oct 14, 2024

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 52-Week HighHere's Why - MarketBeat

Oct 14, 2024

Praxis Precision shares get boost on DEE space acquisition interest By Investing.com - Investing.com South Africa

Oct 14, 2024

Praxis stock soars to 52-week high, hits $68 amid robust gains - Investing.com

Oct 14, 2024

Millennium Management LLC Decreases Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - MarketBeat

Oct 14, 2024

Oct 13, 2024

Praxis Precision Medicines: Great Price Movement, But Still Not Convinced (NASDAQ:PRAX) - Seeking Alpha

Oct 13, 2024

Oct 12, 2024